Nucl Med Mol Imaging.  2015 Dec;49(4):276-283. 10.1007/s13139-015-0361-1.

Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients

Affiliations
  • 1Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea. sghnk@catholic.ac.kr
  • 2Department of Nuclear Medicine, College of Medicine, The Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 3Department of Radiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract


OBJECTIVE
The aim of this study was to evaluate the value of thyroglobulin (Tg) kinetics during preparation of radioiodine ablation for prediction of initial radioiodine ablation failure in thyroid cancer patients.
METHODS
Thyroid cancer patients after total thyroidectomy who underwent radioiodine ablation with 3-4 weeks of hormone withdrawal between May 2011 and January 2012 were included. Consecutive serum Tg levels 5-10 days before ablation (Tg1) and on the day of ablation (Tg2) were obtained. The difference between Tg1 and Tg2 (DeltaTg), daily change rate of Tg (DeltaTg/day) and Tg doubling time (Tg-DT) were calculated. Success of initial ablation was determined by the results of the follow-up ultrasonography, diagnostic radioiodine scan and stimulated Tg level after 6 to 20 months.
RESULTS
A total of 143 patients were included. Failed ablation was reported in 52 patients. Tg2 higher than 5.6 ng/ml and Tg-DT shorter than 4.2 days were significantly related to a high risk of ablation failure. DeltaTg and DeltaTg/day did not show significant correlation with ablation failure.
CONCLUSIONS
Thyroglobulin kinetics on consecutive blood sampling during hormone withdrawal may be helpful in predicting patients with higher risk of treatment failure of initial radioiodine ablation therapy in thyroid cancer patients.

Keyword

Papillary thyroid carcinoma; High-dose I-131 ablation therapy; Thyroglobulin doubling time; Therapeutic failure

MeSH Terms

Follow-Up Studies
Humans
Kinetics
Thyroglobulin*
Thyroid Gland*
Thyroid Neoplasms*
Thyroidectomy
Treatment Failure
Ultrasonography
Thyroglobulin
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr